Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS s...

por Cremers, E. M. P., van Biezen, A., de Wreede, L. C., Scholten, M., Vitek, A., Finke, J., Platzbecker, U., Beelen, D., Schwerdtfeger, R., Volin, L., Harhalakis, N., Blijlevens, N., Nagler, A., Kröger, N., de Witte, T.
Publicado 2016

Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retr...

por Scheid, C, de Wreede, L, van Biezen, A, Koenecke, C, Göhring, G, Volin, L, Maertens, J, Finke, J, Passweg, J, Beelen, D, Cornelissen, J J, Itälä-Remes, M, Chevallier, P, Russell, N, Petersen, E, Milpied, N, Richard Espiga, C, Peniket, A, Sierra, J, Mufti, G, Crawley, C, Veelken, J H, Ljungman, P, Cahn, J Y, Alessandrino, E P, de Witte, T, Robin, M, Kröger, N
Publicado 2017